Back to Search
DAVID JOSEPH, M.D.
M.D.
NPI: 1659351237Individual
Specialties, Licenses & Credentials
Legal Medicine (M.D./D.O.) PhysicianPrimary
Legal Medicine
Code: 209800000X
18703(AZ)
Research & Publications (20)
A small tolerance for catheter displacement in high-dose rate prostate brachytherapy is necessary and feasible.
PMID 19616901·Int J Radiat Oncol Biol Phys·2010
8-other
Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor beta-3.
PMID 19328471·Fertil Steril·2010
8-other
Measuring time to biochemical failure in the TROG 96.01 trial: when should the clock start ticking?
PMID 19577859·Int J Radiat Oncol Biol Phys·2009
4-observational
Exhaled nitric oxide estimation by a simple and efficient noninvasive technique and its utility as a marker of airway inflammation in mice.
PMID 19407252·J Appl Physiol (1985)·2009
7-preclinical
Cardiovascular and metabolic complications during androgen deprivation: exercise as a potential countermeasure.
PMID 19488067·Prostate Cancer Prostatic Dis·2009
6-review
A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer.
PMID 19563641·BMC Cancer·2009
3-trial
Long-term effects of intermittent androgen suppression on testosterone recovery and bone mineral density: results of a 33-month observational study.
PMID 19281463·BJU Int·2009
3-trial
Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation.
PMID 18852703·Prostate Cancer Prostatic Dis·2009
3-trial
Time from decision to incision for cesarean deliveries at a community hospital.
PMID 19300326·Obstet Gynecol·2009
8-other
Recognizing false biochemical failure calls after radiation with or without neo-adjuvant androgen deprivation for prostate cancer.
PMID 19176272·Int J Radiat Oncol Biol Phys·2009
4-observational
Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial.
PMID 18952309·Radiother Oncol·2009
4-observational
Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.
PMID 19064967·J Clin Oncol·2009
8-other
Assuring high quality treatment delivery in clinical trials - Results from the Trans-Tasman Radiation Oncology Group (TROG) study 03.04 "RADAR" set-up accuracy study.
PMID 19017549·Radiother Oncol·2009
3-trial
PSA response signatures - a powerful new prognostic indicator after radiation for prostate cancer?
PMID 18992951·Radiother Oncol·2009
2-rct
Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study.
PMID 19286091·Lancet·2009
3-trial
Uranium sequestration by a marine cyanobacterium, Synechococcus elongatus strain BDU/75042.
PMID 19070485·Bioresour Technol·2009
8-other
The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome.
PMID 19223906·Br J Cancer·2009
8-other
Comprehensive Australasian multicentre dosimetric intercomparison: issues, logistics and recommendations.
PMID 19453538·J Med Imaging Radiat Oncol·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3390 N CAMPBELL AVE, SUITE 110
TUCSON, AZ 85719 - Phone
- (520) 795-7605
Quick Facts
- NPI
- 1659351237
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile